Assertio Therapeutics announces FDA complete response letter for long-acting cosyntropin Oct. 22, 2019
i2020 Accelerator invests in research program at University of Turku for neurodegenerative diseases Oct. 22, 2019
FDA approves Stelara for the treatment of adults with moderate to severely active ulcerative colitis Oct. 22, 2019
RSS